Applicant, as named in the Orange Book

Amphastar Pharms Inc

Next listed expiry: Baqsimi on 23 Sep 2039. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Baqsimi NDA 210134 glucagon	glucagon	23 Sep 2039 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	Earliest generic entry	Basis
Cortrosyn NDA 016750 cosyntropin	cosyntropin	open now no listed protection	no listed protection
Rextovy NDA 208969 naloxone hydrochloride	naloxone hydrochloride	open now no listed protection	no listed protection